Lamivudine Tablet, Film Coated
Product Images NDC 33342-001

4 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 33342-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Lamivudine Fig 1)

Fig-1 (Lamivudine Fig 1)
A line graph showing the proportion of subjects with HIV-1 RNA below 400 copies/mL over 48 weeks of treatment. Two lines represent Lamivudine 150 mg twice daily and 300 mg once daily dosing regimens. The x-axis shows treatment time in weeks, and the y-axis shows the proportion of subjects, highlighting efficacy over time.*
FDA Label Image

Str (Lamivudine Str)

Str (Lamivudine Str)
Chemical structure of Lamivudine depicting its molecular composition with nitrogen, oxygen, sulfur atoms, and specific ring formations consistent with the active pharmaceutical ingredient Lamivudine.*
FDA Label Image

150-60s (Lamivudine Tab 150mg 60s)

150-60s (Lamivudine Tab 150mg 60s)
Lamivudine Tablets, USP 150 mg film-coated oral tablets label, manufactured by Macleods Pharmaceuticals Limited. Packaging displays the proprietary name Lamivudine, strength 150 mg highlighted in green, quantity of 60 tablets, and storage instructions at 20° to 25°C with permitted excursions. Label also shows NDC 33342-001-09 and manufacturing details for Macleods Pharma USA, Inc.*
FDA Label Image

300mg-30s (Lamivudine Tab 300mg 30s)

300mg-30s (Lamivudine Tab 300mg 30s)
Packaging label for Lamivudine Tablets USP 300 mg film-coated tablets, 30 count. The label includes storage instructions, manufacturer Macleods Pharma USA Inc. and Macleods Pharmaceuticals Ltd., India, and notes the prescription-only status. The strength and quantity are clearly marked on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.